For cancer: Tarceva (erlotinib) is a member of a class of drugs called tyrosine kinase inhibitors. It is used to treat certain types of cancers including non small cell lung cancer and pancreatic cancer.
Answered 4/5/2014
5.4k views
Tarceva-TKI : Tarceva (erlotinib) is a tyrosine kinase inhibitor that inhibits the signalling through a uncontrolled (mutated) egfr receptor (epidermal growth factor receptor). Used in lung cancer. May have some use in pancreatic cancer also.
Answered 7/4/2013
5.3k views
6 doctors weighed in across 3 answers
A doctor has provided 1 answer
6 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question